Recently, p16 IHC combined with CDK4 IHC and MDM2 amplification has been proposed as a useful diagnostic biomarker in the differential diagnosis of ALT/WDLPS and DDLPS [39]. The gene discussed is GPT; the disease is dedifferentiated liposarcoma.